DHG Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
DHG Pharmaceutical has a total shareholder equity of ₫5,075.2B and total debt of ₫544.7B, which brings its debt-to-equity ratio to 10.7%. Its total assets and total liabilities are ₫6,201.3B and ₫1,126.1B respectively. DHG Pharmaceutical's EBIT is ₫926.7B making its interest coverage ratio -5.7. It has cash and short-term investments of ₫2,727.7B.
Key information
10.7%
Debt to equity ratio
₫544.73b
Debt
Interest coverage ratio | -5.7x |
Cash | ₫2.73t |
Equity | ₫5.08t |
Total liabilities | ₫1.13t |
Total assets | ₫6.20t |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DHG's short term assets (₫4,745.9B) exceed its short term liabilities (₫1,057.2B).
Long Term Liabilities: DHG's short term assets (₫4,745.9B) exceed its long term liabilities (₫69.0B).
Debt to Equity History and Analysis
Debt Level: DHG has more cash than its total debt.
Reducing Debt: DHG's debt to equity ratio has reduced from 17.6% to 10.7% over the past 5 years.
Debt Coverage: DHG's debt is well covered by operating cash flow (114.9%).
Interest Coverage: DHG earns more interest than it pays, so coverage of interest payments is not a concern.